O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters.Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
